Charcot-Marie-Tooth disease, type 4J (CMT4J) belongs to the genetically heterogeneous group of CMT peripheral sensorimotor polyneuropathy diseases.
Comprehensive, easy-to-understand information about this condition
How we create this content →Connect with organizations supporting the Charcot-Marie-Tooth disease type 4J community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Connect with organizations supporting the Charcot-Marie-Tooth disease type 4J community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Connect with organizations supporting the Charcot-Marie-Tooth disease type 4J community
Helpful links for rare disease information and support
Questions that may be helpful when speaking with your healthcare team
Inheritance patterns describe how genetic conditions are passed from parents to children.
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
2 peer-reviewed sources from PubMed
Common questions about Charcot-Marie-Tooth disease type 4J
AI-Generated Content: This summary was generated using AI. Always consult with qualified healthcare providers for medical guidance.
Organizations with approved therapies for this disease
No approved therapies yet
Research is ongoing — 1 company has orphan drug designations for this disease
Kisho delivers this disease record via API, including phenotypes (HPO), genes, orphan drug designations, screening status, and PAG mapping, with version history and governance.
AI-curated news mentioning Charcot-Marie-Tooth disease type 4J
Updated Feb 3, 2026
A recent German survey study sheds light on the patient journey for those with Charcot-Marie-Tooth Disease, highlighting key challenges and experiences faced by patients. This research contributes valuable insights into the lived experiences of individuals affected by this rare neurological disorder.